BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6624683)

  • 1. Fatty acylcarnitine accumulation and membrane injury in ischemic canine myocardium.
    Chien KR; Sen A; Buja LM; Willerson JT
    Am J Cardiol; 1983 Oct; 52(7):893-7. PubMed ID: 6624683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the possible role of long chain fatty acylcarnitine accumulation in producing functional and calcium permeability changes in membranes during myocardial ischaemia.
    Lamers JM; De Jonge-Stinis JT; Verdouw PD; Hülsmann WC
    Cardiovasc Res; 1987 May; 21(5):313-22. PubMed ID: 3652098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.
    DaTorre SD; Creer MH; Pogwizd SM; Corr PB
    J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():11-22. PubMed ID: 2038071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-carnitine on tissue levels of free fatty acid, acyl CoA, and acylcarnitine in ischemic heart.
    Suzuki Y; Kamikawa T; Kobayashi A; Yamazaki N
    Adv Myocardiol; 1983; 4():549-57. PubMed ID: 6856980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids.
    Chien KR; Han A; Sen A; Buja LM; Willerson JT
    Circ Res; 1984 Mar; 54(3):313-22. PubMed ID: 6421507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H NMR measurement of triacylglycerol accumulation in the post-ischemic canine heart after transient increase of plasma lipids.
    Balschi JA; Hai JO; Wolkowicz PE; Straeter-Knowlen I; Evanochko WT; Caulfield JB; Bradley E; Ku DD; Pohost GM
    J Mol Cell Cardiol; 1997 Feb; 29(2):471-80. PubMed ID: 9140807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool.
    Ford DA; Han X; Horner CC; Gross RW
    Biochemistry; 1996 Jun; 35(24):7903-9. PubMed ID: 8672492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical, ultrastructural and cytochemical study of reperfusion effect on ischemic myocardial injury.
    Fukuhara T
    Jpn Circ J; 1985 Apr; 49(4):432-45. PubMed ID: 3159916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural damage and Ca2(+)-shifts in the canine myocardium subjected to regional incomplete ischemia.
    Vandeplassche G; Thoné F; Hermans C; Borgers M
    Basic Res Cardiol; 1990; 85(4):384-91. PubMed ID: 2241768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid alterations in canine ischemic myocardium. Temporal and topographical correlations with Tc-99m-PPi accumulation and an in vitro sarcolemmal Ca2+ permeability defect.
    Chien KR; Reeves JP; Buja LM; Bonte F; Parkey RW; Willerson JT
    Circ Res; 1981 May; 48(5):711-9. PubMed ID: 7214679
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of glucose-insulin-potassium solution on free fatty acid metabolism in ischemic myocardium.
    Kobayashi A; Kamiya J; Yamashita T; Ishizaka K; Hayashi H; Kamikawa T; Yamazaki N
    Jpn Circ J; 1984 Jun; 48(6):591-5. PubMed ID: 6376844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-carnitine on the cellular distribution of carnitine and its acyl derivatives in the ischemic heart.
    Fujisawa S; Kobayashi A; Hironaka Y; Yamazaki N
    Jpn Heart J; 1992 Sep; 33(5):693-705. PubMed ID: 1289599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible, highly localized alterations in fatty acid metabolism in the chronically ischemic canine myocardium.
    Kang ES; Mirvis DM
    Am J Cardiol; 1984 Aug; 54(3):411-4. PubMed ID: 6465025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding.
    Beller GA; Conroy J; Smith TW
    J Clin Invest; 1976 Feb; 57(2):341-50. PubMed ID: 130383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB; Mody FV; Krivokapich J; Schelbert HR
    J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution of catecholamines in the ischemic zone of the dog heart.
    Muntz KH; Hagler HK; Boulas HJ; Willerson JT; Buja LM
    Am J Pathol; 1984 Jan; 114(1):64-78. PubMed ID: 6691416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that ischemic cell death begins in the subendocardium independent of variations in collateral flow or wall tension.
    Lowe JE; Cummings RG; Adams DH; Hull-Ryde EA
    Circulation; 1983 Jul; 68(1):190-202. PubMed ID: 6851046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
    Kobayashi A; Watanabe H; Yamazaki N
    Jpn Heart J; 1988 Nov; 29(6):831-40. PubMed ID: 3241336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonflow basis for the vulnerability of the subendocardium.
    Eng C; Cho S; Factor SM; Kirk ES
    J Am Coll Cardiol; 1987 Feb; 9(2):374-9. PubMed ID: 3805528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial distribution of [14C]-lidocaine and blood flow in transmural and lateral border zones of ischemic canine myocardium.
    Patterson RE; Weintraub WS; Halgash DA; Miao J; Rogers JR; Kupersmith J
    Am J Cardiol; 1982 Jul; 50(1):63-73. PubMed ID: 7091007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.